Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights that advance precision health, in collaboration with the Lee ...

As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of ...

New research shows that the sugar mix in sodas and fruit juices can make colorectal cancer cells more likely to spread, at ...

Joan Brugge's research into breast cancer is one of hundreds of projects at Harvard caught up in an ongoing dispute with the ...

How fat is distributed in people’s bodies could make a difference to their risk of certain cancers, according to new research ...

The promise of messenger RNA (mRNA) has moved far beyond its pandemic-era spotlight. In oncology, mRNA has emerged as a ...

Researchers have developed a generative AI model that uses large-scale health records to estimate how human health may change ...

Researchers have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Frank Ong, CEO, of Compass Bioinformatic explained, "This partnership between Compass Bioinformatics and Genomenon underscores the industry-leading standards and global reach of our respective ...

From testing, Delphi-2Ms’ predictions matched or exceeded the accuracy of current models for most diseases. It also proved to ...

Flexynesis uses deep learning to evaluate multi-omics data as well as specially processed texts and images, including CT or MRI scans.